Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol

Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol

Guardado en:
Detalles Bibliográficos
Autores principales: Jianguo Li, Xuejun Li, Jing Yuan, Zhihua Liu, Liang Peng, Lina Wu, Shu Zhu, Yongyu Mei, Luping Lin
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Medicine
R
Acceso en línea:https://doaj.org/article/d9ce844af65941faaa4dfe79962a9130
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d9ce844af65941faaa4dfe79962a9130
record_format dspace
spelling oai:doaj.org-article:d9ce844af65941faaa4dfe79962a91302021-12-01T18:00:06ZProspective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol10.1136/bmjopen-2021-0491042044-6055https://doaj.org/article/d9ce844af65941faaa4dfe79962a91302021-10-01T00:00:00Zhttps://bmjopen.bmj.com/content/11/10/e049104.fullhttps://doaj.org/toc/2044-6055Jianguo LiXuejun LiJing YuanZhihua LiuLiang PengLina WuShu ZhuYongyu MeiLuping LinBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 11, Iss 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Jianguo Li
Xuejun Li
Jing Yuan
Zhihua Liu
Liang Peng
Lina Wu
Shu Zhu
Yongyu Mei
Luping Lin
Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol
format article
author Jianguo Li
Xuejun Li
Jing Yuan
Zhihua Liu
Liang Peng
Lina Wu
Shu Zhu
Yongyu Mei
Luping Lin
author_facet Jianguo Li
Xuejun Li
Jing Yuan
Zhihua Liu
Liang Peng
Lina Wu
Shu Zhu
Yongyu Mei
Luping Lin
author_sort Jianguo Li
title Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol
title_short Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol
title_full Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol
title_fullStr Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol
title_full_unstemmed Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol
title_sort prospective, multicentre, randomised controlled trial comparing the seroclearance of hbsag between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with hbv-related liver fibrosis: a study protocol
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/d9ce844af65941faaa4dfe79962a9130
work_keys_str_mv AT jianguoli prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
AT xuejunli prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
AT jingyuan prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
AT zhihualiu prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
AT liangpeng prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
AT linawu prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
AT shuzhu prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
AT yongyumei prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
AT lupinglin prospectivemulticentrerandomisedcontrolledtrialcomparingtheseroclearanceofhbsagbetweencombinationtherapyofpeginterferonalphaandtenofovirwithtenofovirmonotherapyinnucleostideanalogueexperiencedpatientswithhbvrelatedliverfibrosisastudyprotocol
_version_ 1718404780969164800

Ejemplares similares